CENPA and urinary bladder cancer: By integrating transcriptomic, proteomic, and functional analyses, we demonstrate that MAP30 suppresses bladder cancer progression through CENPA downregulation, linking cell cycle regulation, apoptosis, senescence, and immune modulation.